Japan’s cataract surgery devices market has evolved into one of the most advanced and technology-oriented segments in the country’s medical device industry. The history of cataract treatment in Japan dates back several decades, with significant growth beginning in the late 20th century when modern surgical techniques like phacoemulsification replaced traditional manual methods. The introduction of foldable intraocular lenses (IOLs) further revolutionized cataract care by enabling smaller incisions, faster recovery, and improved visual outcomes. Over the years, Japan’s healthcare infrastructure, supported by government initiatives and rapid technological innovation, has allowed cataract surgeries to become a routine and widely accessible procedure. The demand for cataract surgery devices in Japan continues to rise due to its aging population, as more than 28% of citizens are aged 65 or above, leading to a growing prevalence of age-related eye disorders. The market demand is further fueled by increasing awareness about vision health, a strong preference for quality of life among older adults, and the expansion of outpatient eye clinics equipped with high-end surgical devices.

Japanese ophthalmic surgeons are quick adopters of innovation, contributing to the growing use of premium IOLs, such as toric and multifocal lenses, as well as femtosecond laser-assisted systems that provide greater precision. Major domestic manufacturers, including Nidek and Topcon, along with international players like Alcon, Johnson & Johnson Vision, and Bausch + Lomb, have been instrumental in introducing cutting-edge products customized for Japanese consumers.According to the research report " Japan Cataract Surgery Devices Market Research Report, 2030," published by Actual Market Research, the Japan Cataract Surgery Devices market is expected to reach a market size of USD 700 Million by 2030. The Japanese cataract devices market are characterized by a combination of patient education, surgeon engagement, and digital outreach. Hospitals and clinics actively advertise cataract surgery benefits through brochures, online platforms, and local campaigns emphasizing “restoring clear vision” and “enhancing daily life.” Device manufacturers conduct workshops, surgeon training programs, and product demonstrations to strengthen brand trust and loyalty within the professional community. The use of testimonials and technology-focused messaging is common, as patients in Japan value reliability and precision when selecting a medical procedure. Japan maintains one of the most stringent frameworks for medical device approval through the Pharmaceuticals and Medical Devices Agency (PMDA). Manufacturers must comply with rigorous quality, safety, and clinical performance evaluations before receiving certification.

These strict guidelines, while sometimes slowing new product launches, ensure the high standards and reliability that the Japanese healthcare system is known for. Moreover, reimbursement policies under Japan’s universal healthcare system play a crucial role in market growth, as standard cataract surgeries are covered by insurance, while premium IOLs and advanced technologies often fall under self-pay categories, creating room for both affordability and innovation-driven competition. The Pharmaceuticals and Medical Devices Agency (PMDA) enforces strict quality and safety standards for all medical devices, ensuring patient safety and high manufacturing benchmarks. Though the approval process can be lengthy, it ensures that only devices meeting rigorous standards enter the market, preserving Japan’s reputation for medical excellence.Intra-ocular lenses (IOLs) represent the largest and most critical product category, driven by Japan’s high cataract prevalence and its population’s preference for excellent visual outcomes. The majority of cataract surgeries in Japan are performed using foldable acrylic IOLs, which allow for minimally invasive procedures through small incisions. Premium IOLs, including multifocal, toric, and extended-depth-of-focus lenses, are gaining steady traction, particularly among patients opting for out-of-pocket upgrades beyond the coverage of Japan’s universal health insurance system.

Japanese manufacturers, alongside global leaders, are at the forefront of IOL innovation, focusing on lens materials, biocompatibility, and optical precision. Phacoemulsification systems form the backbone of Japan’s cataract surgery infrastructure, with nearly all surgeries being performed using modern phaco platforms. Hospitals and eye clinics prioritize systems offering enhanced fluidics, energy efficiency, and real-time feedback to ensure surgical precision and safety. The country’s emphasis on advanced technology integration has resulted in widespread adoption of premium phaco consoles equipped with intelligent sensors and digitally assisted controls. Ophthalmic viscoelastic devices (OVDs) are another indispensable category, used in every procedure to maintain chamber stability and protect corneal endothelium. Japan’s OVD market benefits from the presence of both domestic suppliers and leading international brands that provide high-purity, high-viscosity formulations tailored for precision surgeries.

Femtosecond laser systems, while representing a niche market segment, are increasingly being utilized in top-tier hospitals and private eye centers, as Japanese patients show growing interest in laser-assisted cataract surgery for its superior accuracy and lower complication rates.Hospitals dominate Japan’s cataract surgery devices market, reflecting the country’s healthcare structure, where most surgeries are conducted under the national health insurance system. University and municipal hospitals across Japan are equipped with advanced surgical infrastructure, ensuring consistent patient access to modern phacoemulsification systems, OVDs, and standard IOLs. The universal insurance scheme covers most basic cataract procedures, making surgery widely accessible to the elderly population. However, private hospitals and specialized eye clinics are gaining importance as centers for innovation and patient-centric care, offering premium IOLs and femtosecond-assisted procedures not fully covered by insurance. These private institutions, particularly in metropolitan areas like Tokyo, Osaka, and Yokohama, focus on enhancing patient experience and visual quality, attracting individuals willing to pay extra for advanced technologies. Ambulatory surgery centers (ASCs) are also becoming increasingly popular, encouraged by the country’s shift toward efficient outpatient surgical care that minimizes hospital stays and reduces healthcare costs.

These centers rely on compact phaco platforms, advanced imaging systems, and premium consumables to deliver high-quality care in a streamlined environment. Ophthalmology clinics play an essential role in Japan’s care continuum, providing preoperative examinations, biometry, and postoperative management, often referring complex cases to hospital-based surgeons. Academic and research institutes contribute significantly to the evolution of cataract technologies, frequently partnering with device manufacturers for clinical studies and innovation in IOL design and surgical systems. Japan’s regulatory environment ensures stringent quality standards for all ophthalmic devices, fostering trust among surgeons and patients alike.Considered in this report• Historic Year: 2019• Base year: 2024• Estimated year: 2025• Forecast year: 2030Aspects covered in this report• Cataract Surgery Devices Market with its value and forecast along with its segments• Various drivers and challenges• On-going trends and developments• Top profiled companies• Strategic recommendationBy Product Type• Intra-ocular Lenses (IOL)• Phacoemulsification Systems• Ophthalmic Viscoelastic Devices• Femtosecond Laser Systems• Others (Knives and Low-Cost Consumables)By End User• Hospitals• Ambulatory Surgery Centers• Ophthalmology Clinics• Academic and Research Institutes.